LIXTE, a listed US stock company, spends $2.6 million to buy cryptocurrency

Huobi HTX reported that Nasdaq-listed company LIXTE Biotechnology Holdings (stock codes: LIXT and LIXTW) announced on September 10 that it has purchased 10.5 bitcoins and 300 Ethereum for the first time, with a total value of approximately US$2.6 million as part of its fund diversification strategy. According to the announcement, cryptocurrencies currently account for 43.6% of LIXTE fund holdings, and the company's board of directors has approved the increase in the allocation ratio of cryptocurrencies to 50%. Geordan Pursglove, chairman and CEO of LIXTE, said the move aims to build a balanced and flexible digital asset strategy to enhance the company's adaptability and long-term growth potential in the digital economy. Previous news, LIXTE, a biotech company listed on the US stock market, plans to allocate up to 25% of its capital reserves to digital assets such as Bitcoin.